Background. Primary graft dysfunction (PGD) is a predominant cause of early morbidity and mortality after lung transplantation. Although substantial work has been done to understand risk factors for PGD in terms of donor, recipient, and surgical factors, little is understood regarding the potential role of anaesthetic management variables in its development.
Lung transplantation is the definitive treatment for endstage lung disease with 1800 transplants per year performed worldwide.
1 Despite 1 yr survival approaching 80%, primary graft dysfunction (PGD) remains a predominant cause of early morbidity and mortality. PGD is variably reported with an incidence of 10-50% and a 30 or 90 day mortality of 14-63% of those affected, 2 -5 the variation due in part to inconsistencies in definitions. The International Society of Heart and Lung Transplantation (ISHLT) published recommendations on the classification and nomenclature to be used in PGD 6 with severity quantified by the measured ratio of Pa O 2 to FI O 2 in combination with the presence or absence of infiltrates on the chest X-ray (CXR) from 0 to 72 h after operation. However, in view of inherent inconsistencies in CXR reporting, a modified ISHLT grading system has been subsequently described and validated, 4 based solely on the observed Pa O 2 /FI O 2 ratio (Table 1) .
PGD presents a wide spectrum of disease severity characterized by varying degrees of impairment of gas exchange and is associated with delayed extubation, prolonged intensive care and hospital length of stay (LOS), increased early mortality, and worse long-term outcome among survivors. 7 -11 Treatment is essentially supportive. Numerous studies have attempted to define factors associated with increased risk of PGD. Most published work in this area has focused on donor variables, preoperative recipient variables, surgical factors, and early postoperative management. 5 12-16 However, there is a current gap in the literature assessing the impact of anaesthetic management variables on early graft function after lung transplantation. The aim of the current study is to explore the relationship between such factors and early lung allograft function. We hypothesize that anaesthetic management factors will account for significant postoperative outcome variability, providing potential targets for therapeutic strategies to optimize early graft function.
Methods

Study group
We retrospectively studied 107 consecutive patients undergoing lung transplantation at The Alfred Hospital between May 2004 and January 2007. This group comprised 84 bilateral transplants (two re-transplants) and 23 single transplants. Combined heart -lung transplants were excluded from analysis.
Data extraction and definitions
After IRB approval, data were retrospectively extracted from the medical record by two trained reviewers.
Preoperative recipient variables
Baseline patient characteristics were recorded and also the patient's underlying lung pathology, classified as obstructive, restrictive, or vascular [including primary pulmonary hypertension (PPH)]. Obstructive pathology was further classified as cystic fibrosis (CF) or non-CF related.
Donor variables
These included age, gender, donor Pa O 2 at retrieval, inotrope use at organ procurement, preservation solution used, and donor organ ischaemic time. For bilateral transplants, the ischaemic time was taken as the ischaemic time of the second lung.
Intraoperative variables
Operation (bilateral vs single), duration of surgery, epidural catheterization, antifibrinolytic, inhaled nitric oxide or cardiopulmonary bypass (CPB) use, total volume of i.v. fluid administered including volume of individual fluid components, central venous (CVP), and pulmonary artery pressures (PAS/PAD), inotrope and vasodilator use, and, in bilateral transplantation, time at which the entire cardiac output was directed through the first implanted lung were all recorded. CVP-1 was defined as CVP immediately before induction of anaesthesia. Where not available, the first recorded CVP after induction of anaesthesia was used. CVP-2 was defined as the first recorded CVP in the intensive care unit (ICU). Where not available, the last recorded CVP before departing the operating room (OR) was used. The same definitions applied to recording pulmonary artery pressures. Vasoactive medication use was recorded as peak sustained dose (.30 min) during surgery. Data were recorded for epinephrine, norepinephrine, and sodium nitroprusside. Biochemical data during surgery were recorded, including highest and lowest measured haemoglobin concentration, highest recorded Pa CO 2 , lowest recorded arterial pH, and highest recorded blood glucose level.
Postoperative variables
A new management protocol to standardize postoperative cardiorespiratory and fluid management of these patients 17 was introduced in September 2005 and was included for analysis.
Outcome variables
Pa O 2 /FI O 2 ratio was recorded at time 0, 3, 6, 12, 24, 48 , and 72 h post-transplantation and time to extubation, ICU LOS, and 30 day mortality.
Donor and recipient matching
Donor assessment and management and donor -recipient matching proceeded according to standard protocols described elsewhere. 18 19 Although donor selection is based around standard criteria, marginal donors are commonly considered and used within our institution. Before operation, a panel-reactive antibody assay was used to screen for preformed antibodies to human leucocyte antigens and prospective donor-recipient T, and B-cell cross-matching was performed.
Lung procurement and preservation
Lung procurement and preservation followed standard procedures. 20 21 Attempts were made to optimize donor haemodynamics with i.v. fluid titrated to a CVP of 10 mm Hg . Ventilatory frequency was adjusted to achieve the desired Pa CO 2 and FI O 2 reduced to 0.5-0.8 as tolerated, while maintaining the Sp O 2 94%. TOE facilitated routine intraoperative examination of pulmonary venous anastomoses before leaving the OR. 22 Although sited before operation, epidural catheters were only used once both transplanted lungs were reperfused and the patient was haemodynamically stable. After a loading dose of fentanyl 100 mg, a maintenance infusion of ropivacaine 2 mg ml 21 and fentanyl 2 mg ml 21 was commenced at 6 -10 ml h 21 .
Postoperative management
Before September 2005, postoperative management in the ICU aimed at ensuring adequate end-organ perfusion. Although low filling pressures were targeted, they were not aggressively pursued. 13 From September 2005, a new postoperative fluid management regimen was instituted in our lung transplant recipients, which has been previously described. 17 This encompassed respiratory and cardiovascular management algorithms, targeting a CVP ,7 mm Hg where mean arterial pressure and cardiac index permitted. The protocol provided an algorithm for early extubation where the Pa O 2 /FI O 2 ratio was .200. Inhaled nitric oxide was used (20 ppm) if there was increasing pulmonary artery pressures or decreasing oxygenation and extracorporeal membrane oxygenation if required. Immunosuppression was achieved as per protocols previously published. 18 All donors and recipients received methylprednisolone (1 g) intraoperatively. Recipients also received immunosuppressive induction with cyclosporine and azathioprine at the time of surgery. All patients received prophylactic antibiotics on the basis of known or suspected donor and recipient microbiology results and ganciclovir for cytomegalovirus prophylaxis where indicated.
Statistical analysis
Statistical analysis was performed with Stata version 10 (StataCorp, College Station, TX, USA). Continuous data were assessed for normality and expressed as mean (SD) or median and inter-quartile range. Categorical data are expressed as count and proportions. The primary outcome was to determine if anaesthesia management factors were significantly associated with early postoperative allograft function measured by the Pa O 2 /FI O 2 ratio. Using the Cox proportional hazards, an initial assessment was made of the relationship between Pa O 2 /FI O 2 at each measured time point (0-72 h after operation) with the outcomes of both time to extubation and ICU LOS. The time point with the strongest statistical association with clinical outcome was selected as the dependent variable for further exploratory analysis with intraoperative data.
After selecting the time point for assessment of graft function (Pa O 2 /FI O 2 ), univariate regression analysis with each of the explanatory variables in our data set was performed, including donor lung preservation protocol and postoperative fluid management regimen and also factors previously demonstrated to be associated with early graft function for potential inclusion in a multivariate model. 2 5 7 12 -14 Variables were assessed for normality and mathematically transformed where appropriate. Factors significant to a P-value of 0.2 on univariate analysis were incorporated into a multivariate model. Manual backward stepwise elimination was performed, excluding the most non-significant variable at each step. This process continued until there were at least 10 outcomes for each variable remaining in the model, further elimination proceeding only if it produced a more parsimonious model. Variables that remained are expressed as regression coefficient, with P-value and 95% confidence interval (CI). A multivariate Cox regression model was then used to assess the relationship between the variables retained in the linear regression model and clinical outcomes of both time to extubation and ICU LOS. These results are expressed as hazard ratio (HR) with P-value and 95% CI. Further sensitivity analyses were performed to assess the effect of specific subgroups or adding potential confounding variables to the results.
Results
Baseline characteristics of donors and recipients along with donor operative data are provided in Table 2 . Recipient intraoperative variables are detailed in Table 3 . Median time to extubation was 0.9 days (inter-quartile range 0.5 -2.2), median ICU LOS was 3.2 days (interquartile range 2 -6), and 30 day mortality was 2%. Forty-three subjects (40%) had at least one Pa O 2 /FI O 2 ,200 recorded within the first 6 postoperative hours. However, by 12 h after operation, only 13 subjects (12%) had a Pa O 2 / FI O 2 ratio ,200, this number continuing to decline through the remainder of the measurement period (Fig. 1) (31) Anaesthesia and lung transplant outcomes analysis was reduced to 68. Stepwise elimination proceeded until four variables remained. Likelihood testing confirmed this to be the most parsimonious model (Table 5) For further sensitivity analysis, patients with a pulmonary vascular aetiology for their underlying lung disease were excluded with no significant change in results of multivariate analysis. Further exclusion of patients requiring CPB support to facilitate surgery resulted in i.v. colloid administration failing to achieve significance albeit with a minimal change to the regression coefficient (b coefficient 236 mm Hg, 95% CI 284 to 12 mm Hg, P¼0.14). Repeating the analysis by each class of recipient pathology, the inverse association between volume of colloid and Pa O 2 /FI O 2 (T12) persisted (b-regression coefficient range: 231 to 2105 mm Hg), although with reduced numbers in each group, it was no longer statistically significant.
Cox regression techniques were used to assess the relationship between the variables derived from the multivariate linear regression model and the outcomes of time to extubation and ICU LOS (Table 6 ). Intraoperative colloid was significantly associated with a reduced rate of extubation (HR 0.65, 95% CI 0.49 -0.84, P¼0.001) as was a pulmonary vascular aetiology for the primary lung disease (HR 0.25, 95% CI 0.07 -0.90, P¼0.03). Intraoperative colloid remained significantly associated with a reduced rate of extubation, despite excluding cases performed with the aid of CPB (HR 0.63, 95% CI 0.46-0.87, P¼0.01) or cases performed without the use of an epidural (HR 0.66, 95% CI 0.48 -0.90, P¼0.01). Repetition of the analysis by pre-transplant recipient lung pathology demonstrated a consistent albeit non-significant trend towards a reduced HR for time to extubation across each group. There was a trend for increasing volume of i.v. colloid to be associated with a reduced rate of ICU discharge (HR 0.79, 95% CI 0.31 -1.02, P¼0.07) whereas increasing PA-systolic pressure-2 was associated with a reduced rate of ICU discharge (HR 0.96, 95% CI 0.93-0.99, P¼0.01). However, adjusting the analysis for either epidural use or CVP-2 rendered the association between PA pressure and rate of ICU discharge non-significant. Further repetition of the analysis according to pretransplant lung pathology demonstrated a consistent trend across groups towards a reduced rate of ICU discharge with increasing intraoperative colloid. Colloid volume was included in the Cox model without the need for log e transformation and model checking confirmed that neither model violated the assumptions of proportional hazards.
Discussion
Previous studies investigating the association between intraoperative variables and PGD have focused on single interventions or measures, such as the use of inhaled nitric oxide, aprotinin, or CPB, different preservation solutions, and flushing techniques of the lungs and ischaemic times. 21 23 -26 In the current study, multivariate regression analysis is used to explore the association between a large number of intraoperative and anaesthesia management variables and early allograft function. We found an independent inverse association between volume of intraoperative colloid, comprising predominantly gelatin, and Pa O 2 /FI O 2 12 h post-transplantation. Furthermore, each additional litre of intraoperative colloid was associated with a 35% reduction in the rate of extubation (HR 0.65, 95% CI 0.49-0.84, P¼0.001) and a trend towards a reduced rate of ICU discharge (HR 0.79, 95% CI 0.31-1.02, P¼0.07).
Although the ISHLT PGD guideline recommends assessment of Pa O 2 /FI O 2 at the time points of 0, 24, 48, and 72 h post-transplant, 6 Oto and colleagues 27 have demonstrated a significant variation in the ratio within the first 12 postoperative hours, stabilizing thereafter. They further note the early predictive value of Pa O 2 /FI O 2 (T12) for the clinical outcomes of time to extubation and ICU LOS and our data are consistent with this finding. Furthermore, the T12 time point may represent an ideal time for assessing the impact of intraoperative interventions, allowing time for optimal ventilation to be established in the ICU and before the impact of later interventions become more prominent. The stabilization of Pa O 2 /FI O 2 beyond 12 h justifies the imputation of Pa O 2 /FI O 2 (T24) data where T12 data were unavailable.
It is important to consider potential sources of confounding. Elevated CVP has been associated with early graft dysfunction and prolonged time to extubation. 13 However, there was no association between volume of colloid Anaesthesia and lung transplant outcomes administered and CVP-2 (r¼0.03) in the current study cohort, nor did adjusting for CVP-2 alter the association between colloid and Pa O 2 /FI O 2 (T12). Furthermore, there was no association between colloid administration and either inotrope use or pulmonary artery diastolic pressure supporting an effect of colloid that is independent of cardiac and haemodynamic performance. CPB is another potential confounder with the altered capillary permeability and inflammatory response that it may induce along with the obligatory volume of colloid (4% albumin) these patients receive from the circuit prime. 28 Excluding these patients from analysis resulted in minimal change to the observed association between Pa O 2 /FI O 2 (T12) and volume of intraoperative colloid (Gelofusine w ) (b coefficient 250 mm Hg, 95% CI 2106 to 5 mm Hg, P¼0.07), although the reduction in number of subjects for analysis results in a widening of confidence limits and loss of statistical significance, making interpretation difficult. Although a number of studies have attempted to define the association between CPB and early graft dysfunction, they have produced conflicting results and the role of CPB as an independent risk factor for PGD remains controversial. 16 Intraoperative colloid was associated with a 35% reduction in the rate of extubation for every additional litre administered. This relationship persisted, despite a detailed sensitivity analysis with both exclusion of potentially confounding subgroups and manual addition of potential confounding variables to the model, supporting the clinical relevance of the observed inverse association between colloid and Pa O 2 / FI O 2 (T12). A vascular aetiology for the underlying lung disease (PPH in our population) was also significantly associated with a reduced rate of extubation. This has been previously documented as a risk factor for PGD, supporting the consistency of the current data set with previous reports.
PGD is characterized by diffuse alveolar damage 29 30 and increased capillary permeability, 31 32 and the recent ISHLT working group report makes general recommendation to avoid excessive i.v. fluid in postoperative management of these patients. 33 However, few previous studies have explored the relationship between perioperative fluid therapy and early graft function. Pilcher and colleagues 14 found no association between postoperative fluid balance and Pa O 2 /FI O 2 ratios in the first 24 h after operation, but they did not assess the effect of specific fluid components. Although we also found no association between total i.v. fluid volume, crystalloid or blood products given intraoperatively, and early graft function, the finding of a highly significant inverse association between volume of intraoperative colloid and Pa O 2 /FI O 2 (T12) requires further consideration. One potential explanation for this finding may be the increased capillary permeability occurring with PGD allowing leakage of relatively large molecules of colloid solution into the extravascular lung space. The complete absence of lymphatic drainage in the transplanted lung may further slow the removal of these oncotically active molecules from the lung. Although this may seem counter-intuitive given the physico-chemical properties of colloid solutions for maintaining intravascular oncotic pressure, 34 the leakage of radio-labelled transferrin (molecular weight 75 000 Da) and other proteins into extravascular lung tissue is well described in patients with acute respiratory distress syndrome. 35 36 Gelofusine w was the predominant intraoperative colloid in this series of patients, accounting for more than 90% of administered colloid volume. It is a succinylated gelatin, molecular weight 30 000 Da, which undergoes minimal metabolism and is excreted largely unchanged in the urine. Although a 4% albumin solution was added to the CPB priming volume as described, this represented only 7.5% of total colloid volume administered, always in the context of the CPB prime. Therefore, separate analysis was not performed. It is unclear if our findings may be generalized to other colloid solutions. Although the introduction of a postoperative fluid management algorithm was not associated with early graft function, the data were unable to assess the impact of the algorithm on specific component fluid volumes administered through the early postoperative period, and this may have provided further useful information.
Increasing pulmonary artery systolic pressure at end-operation was associated with a reduced rate of ICU discharge, although the association was lost when the use of CPB was adjusted for or when such cases were excluded from the analysis. Previous studies assessing the relationship between pulmonary artery pressures and early graft function have focused on elevations in preoperative pulmonary artery pressure, the significance of which remains uncertain. 5 16 Although postoperative elevations in pulmonary artery pressure may indicate serious problems with pulmonary vascular anastomoses, there was no evidence of this in the current series. Furthermore, the absence of an association between pulmonary artery pressures and either Pa O 2 /FI O 2 (T12) or time to extubation makes this association difficult to interpret, raising the likelihood that it represents a spurious finding.
The lack of association between many of the other variables analysed, including those that may be considered issues of anaesthesia management, and measures of early graft function should not be interpreted to mean that their diligent control is unnecessary. There are two other conservative and more likely interpretations of this finding. The first, a classic type II error, is the possibility of missing significant associations in a data set of limited size. The second plausible explanation is that within the bounds of which these many variables were maintained, they did not exert an observable effect on the outcome. However, our data make no inference as to the potential effect of these variables outside the limits that we observed.
Study limitations
Despite a detailed sensitivity analysis, the possibility of unrecognized or unmeasured confounding cannot be eliminated in a retrospective study and our results should be interpreted with caution. Although we describe a number of positive findings, regression methods can only show association. These results are best used to generate hypotheses for subsequent testing under appropriate conditions.
Pa O 2 /FI O 2 was chosen as the primary outcome in this study as it is an accepted measure of early graft function in lung transplantation and forms the basis for the quantification of PGD. Furthermore, in an exploratory study, the continuous nature of this outcome optimizes the possibility of detecting significant associations that may otherwise be missed with a binary outcome such as severe PGD. It is a non-specific outcome and may represent pathology other than PGD, such as atelectasis, sputum plugging, pneumothorax, or other mechanical vascular pathologies, although the association between intraoperative colloid and increased time to extubation supports the potential clinical relevance of this finding. The 12 h time point for measurement of Pa O 2 /FI O 2 was selected for further analysis in this study on the basis of demonstrated association with duration of mechanical ventilation and ICU LOS. Despite the importance of these short-term outcomes, the current study is unable to make any inference of association between colloid volume and later outcomes.
Multiple analyses have been conducted enhancing the possibility of a type I error, although the consistently adverse association of intraoperative colloid with multiple outcomes lessens that likelihood. The sample size of 107 cases is small compared with the number of potential explanatory variables considered, limiting power, and increasing potential for type II errors. Our findings would be further strengthened if reproduced by other clinical units.
Conclusion
We have performed a retrospective analysis of factors associated with early graft function in lung transplantation, focusing on anaesthetic management factors. We have demonstrated an inverse association between volume of intraoperative colloid, comprising predominantly gelatin, and Pa O 2 /FI O 2 ratio 12 h after operation, and also a reduced rate of extubation. These associations persist, despite adjusting for potential confounding factors, providing potential hypotheses for subsequent testing. Further studies are required to confirm these findings and to explore potential mechanisms through which these associations may act.
